During the past decade, The First Affiliated Hospital of Guangxi Medical University conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 5 clinical trials were completed, i.e. on average, 5.2% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 2 clinical trials were completed. i.e. 4.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First Affiliated Hospital of Guangxi Medical University" #1 sponsor was "First Affiliated Hospital of Guangxi Medical University" with 9 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Guangxi Medical University" with 5 trials sponsored and "Nanfang Hospital of Southern Medical University" with 5 trials sponsored. Other sponsors include 94 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital of Guangxi Medical University" #1 collaborator was "First Affiliated Hospital of Guangxi Medical University" with 12 trials as a collaborator, "Peking University First Hospital" with 5 trials as a collaborator, "The First Hospital of Jilin University" with 5 trials as a collaborator, "Xiangya Hospital of Central South University" with 5 trials as a collaborator and "Qilu Hospital of Shandong University" with 4 trials as a collaborator. Other collaborators include 288 different institutions and companies that were collaborators in the rest 205 trials.

According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital of Guangxi Medical University" are "Nasopharyngeal Carcinoma" (6 trials), "Chronic Hepatitis B" (5 trials), "Adenocarcinoma" (3 trials), "Coronary Artery Disease" (3 trials) and "Hepatitis B, Chronic" (3 trials). Many other conditions were trialed in "The First Affiliated Hospital of Guangxi Medical University" in a lesser frequency.

Most popular intervention types in "The First Affiliated Hospital of Guangxi Medical University" are "Drug" (100 trials), "Device" (8 trials), "Other" (8 trials), "Procedure" (8 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Toripalimab" (4 trials), "placebo" (4 trials), "Cyclophosphamide" (3 trials) and "DDP" (3 trials). Other intervention names were less common.

The vast majority of trials in "The First Affiliated Hospital of Guangxi Medical University" are 125 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The First Affiliated Hospital of Guangxi Medical University". 4 are not yet recruiting, 41 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in The First Affiliated Hospital of Guangxi Medical University, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in The First Affiliated Hospital of Guangxi Medical University, 6 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 28 trials, and there were also 19 trials that are defined as “Not Applicable".